Infliximab

INFLIXIMAB treats autoimmune conditions, such as psoriasis, arthritis, Crohn's disease, and ulcerative colitis. It works by slowing down an overactive immune system. It belongs to a group of medications called TNF inhibitors. It is a monoclonal antibody.

With the Patient Assistance Program from Johnson & Johnson Patient Assistance Foundation, Inc., if you meet program requirements and are approved, you’ll receive your medication for up to one year.